Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China
· Delayed Price · Currency is CNY 21.30
+0.75 (3.65%)
Mar 10, 2026, 3:04 PM CST
Hubei Goto Biopharm Revenue
Hubei Goto Biopharm had revenue of 152.67M CNY in the quarter ending September 30, 2025, with 16.04% growth. This brings the company's revenue in the last twelve months to 626.28M, up 14.55% year-over-year. In the year 2024, Hubei Goto Biopharm had annual revenue of 536.60M, down -5.26%.
Revenue (ttm)
626.28M
Revenue Growth
+14.55%
P/S Ratio
3.78
Revenue / Employee
766.56K
Employees
817
Market Cap
2.36B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Gdk Biological Technology | 113.23M |
| Guiyang Xintian Pharmaceutical | 755.34M |
| Zhejiang East Asia Pharmaceutical | 831.56M |
| Jiangsu CoWin Biotech | 193.05M |
| Hunan Nucien Pharmaceutical | 141.93M |
| Shanghai Serum Bio-Technology | 196.21M |
| Shandong Sito Bio-technology | 954.76M |
| Jilin Jian Yisheng Pharmaceutical | 639.10M |